FDA Inspection 1039470 — BPL Plasma, Inc.

BPL Plasma, Inc. — FEI 3013195380

The FDA completed an inspection of BPL Plasma, Inc. on Feb 2, 2018 in Austin, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 2, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Austin, TX (United States)

Citations

IDCFRDescription
1503321 CFR 610.47(a)Lookback System [Collecting Establishment]
908921 CFR 600.14(c)When to report
9821 CFR 606.100(c)Thorough investigations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.